148 related articles for article (PubMed ID: 15030596)
1. The characteristics of erythema induced by topical 5-aminolaevulinic acid photodynamic therapy.
Clark C; Dawe RS; Moseley H; Ferguson J; Ibbotson SH
Photodermatol Photoimmunol Photomed; 2004 Apr; 20(2):105-7. PubMed ID: 15030596
[TBL] [Abstract][Full Text] [Related]
2. Topical aminolaevulinic acid- and aminolaevulinic acid methyl ester-based photodynamic therapy with red and violet light: influence of wavelength on pain and erythema.
Mikolajewska P; Iani V; Juzeniene A; Moan J
Br J Dermatol; 2009 Nov; 161(5):1173-9. PubMed ID: 19785604
[TBL] [Abstract][Full Text] [Related]
3. Pain associated with photodynamic therapy using 5-aminolevulinic acid or 5-aminolevulinic acid methylester on tape-stripped normal skin.
Wiegell SR; Stender IM; Na R; Wulf HC
Arch Dermatol; 2003 Sep; 139(9):1173-7. PubMed ID: 12975159
[TBL] [Abstract][Full Text] [Related]
4. Prostaglandin E2 and nitric oxide mediate the acute inflammatory (erythemal) response to topical 5-aminolaevulinic acid photodynamic therapy in human skin.
Brooke RC; Sidhu M; Sinha A; Watson RE; Friedmann PS; Clough GF; Rhodes LE
Br J Dermatol; 2013 Sep; 169(3):645-52. PubMed ID: 23909846
[TBL] [Abstract][Full Text] [Related]
5. A novel skin cream containing a mixture of human growth factors and cytokines for the treatment of adverse events associated with photodynamic therapy.
Gold MH; Biron J
J Drugs Dermatol; 2006 Sep; 5(8):796-8. PubMed ID: 16989195
[TBL] [Abstract][Full Text] [Related]
6. Randomized, double-blind, prospective study to compare topical 5-aminolaevulinic acid methylester with topical 5-aminolaevulinic acid photodynamic therapy for extensive scalp actinic keratosis.
Moloney FJ; Collins P
Br J Dermatol; 2007 Jul; 157(1):87-91. PubMed ID: 17501954
[TBL] [Abstract][Full Text] [Related]
7. Effect of 5-aminolevulinic acid-mediated photodynamic therapy on MCF-7 and MCF-7/ADR cells.
Tsai T; Hong RL; Tsai JC; Lou PJ; Ling IF; Chen CT
Lasers Surg Med; 2004; 34(1):62-72. PubMed ID: 14755426
[TBL] [Abstract][Full Text] [Related]
8. Correlations between photoactivable porphyrins' fluorescence, erythema and the pain induced by PDT on normal skin using ALA-derivatives.
Barge J; Glanzmann T; Zellweger M; Salomon D; van den Bergh H; Wagnières G
Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):683-93. PubMed ID: 24284128
[TBL] [Abstract][Full Text] [Related]
9. Acute phototoxicity with urticarial features during topical 5-aminolaevulinic acid photodynamic therapy.
Kerr AC; Ferguson J; Ibbotson SH
Clin Exp Dermatol; 2007 Mar; 32(2):201-2. PubMed ID: 17244343
[No Abstract] [Full Text] [Related]
10. Topical aminolaevulinic acid-based photodynamic therapy as a treatment option for psoriasis? Results of a randomized, observer-blinded study.
Radakovic-Fijan S; Blecha-Thalhammer U; Schleyer V; Szeimies RM; Zwingers T; Hönigsmann H; Tanew A
Br J Dermatol; 2005 Feb; 152(2):279-83. PubMed ID: 15727639
[TBL] [Abstract][Full Text] [Related]
11. Topical aminolaevulinic acid-photodynamic therapy for the treatment of acne vulgaris: a study of clinical efficacy and mechanism of action.
Pollock B; Turner D; Stringer MR; Bojar RA; Goulden V; Stables GI; Cunliffe WJ
Br J Dermatol; 2004 Sep; 151(3):616-22. PubMed ID: 15377348
[TBL] [Abstract][Full Text] [Related]
12. Topical photodynamic therapy is immunosuppressive in humans.
Matthews YJ; Damian DL
Br J Dermatol; 2010 Mar; 162(3):637-41. PubMed ID: 19863500
[TBL] [Abstract][Full Text] [Related]
13. Thioredoxin upregulation by 5-aminolaevulinic acid-based photodynamic therapy in human skin squamous cell carcinoma cell line.
Kuhara T; Watanabe D; Akita Y; Takeo T; Ishida N; Nakano A; Yamashita N; Ohshima Y; Kawada M; Yanagishita T; Tamada Y; Matsumoto Y
Photodermatol Photoimmunol Photomed; 2008 Jun; 24(3):142-6. PubMed ID: 18477133
[TBL] [Abstract][Full Text] [Related]
14. Aminolevulinic acid (Levulan) in photodynamic therapy of actinic keratoses.
Lang K; Schulte KW; Ruzicka T; Fritsch C
Skin Therapy Lett; 2001 Sep; 6(10):1-2, 5. PubMed ID: 11685275
[TBL] [Abstract][Full Text] [Related]
15. Development of a keratoacanthoma after topical photodynamic therapy with 5-aminolevulinic acid.
Maydan E; Nootheti PK; Goldman MP
J Drugs Dermatol; 2006 Sep; 5(8):804-6. PubMed ID: 16989196
[TBL] [Abstract][Full Text] [Related]
16. Clinical and immunohistochemical evaluation of psoriatic plaques treated with topical 5-aminolaevulinic acid photodynamic therapy.
Fransson J; Ros AM
Photodermatol Photoimmunol Photomed; 2005 Dec; 21(6):326-32. PubMed ID: 16313245
[TBL] [Abstract][Full Text] [Related]
17. Optimization of photodynamic therapy with a novel self-adhesive 5-aminolaevulinic acid patch: results of two randomized controlled phase III studies.
Hauschild A; Stockfleth E; Popp G; Borrosch F; Brüning H; Dominicus R; Mensing H; Reinhold U; Reich K; Moor AC; Stocker M; Ortland C; Brunnert M; Szeimies RM
Br J Dermatol; 2009 May; 160(5):1066-74. PubMed ID: 19222455
[TBL] [Abstract][Full Text] [Related]
18. Phototoxic reactions in healthy volunteers following photodynamic therapy with methylaminolevulinate cream or with cream containing 5-aminolevulinic acid: a phase II, randomized study.
Steinbauer J; Schreml S; Karrer S; Ackermann G; Babilas P; Landthaler M; Szeimies RM
Photodermatol Photoimmunol Photomed; 2009 Oct; 25(5):270-5. PubMed ID: 19747247
[TBL] [Abstract][Full Text] [Related]
19. Aminolaevulinic acid diffusion characteristics in 'in vitro' normal human skin and actinic keratosis: implications for topical photodynamic therapy.
McLoone N; Donnelly RF; Walsh M; Dolan OM; McLoone S; McKenna K; McCarron PA
Photodermatol Photoimmunol Photomed; 2008 Aug; 24(4):183-90. PubMed ID: 18717959
[TBL] [Abstract][Full Text] [Related]
20. Photodynamic therapy using aminolaevulinic acid for patients with nonhyperkeratotic actinic keratoses of the face and scalp: phase IV multicentre clinical trial with 12-month follow up.
Tschen EH; Wong DS; Pariser DM; Dunlap FE; Houlihan A; Ferdon MB;
Br J Dermatol; 2006 Dec; 155(6):1262-9. PubMed ID: 17107399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
